Thus, theability to modulate GILZ could provide the opportunity to not only address oralhealth consequences of salivary hypofunction (i.e., dental caries, gingivitis, andperiodontitis) but could lead to gene-based therapies to address other gravesystemic consequences of SS. This evidence concerns the gene TSC22D3 and gingivitis.